•
Jun 30, 2021

Bruker Q2 2021 Earnings Report

Bruker's financial performance grew strongly driven by robust demand and strong recovery.

Key Takeaways

Bruker Corporation reported a strong second quarter in 2021, with a revenue increase of 34.4% compared to the second quarter of 2020. GAAP EPS was $0.38 and non-GAAP EPS was $0.44. The company is raising its fiscal year 2021 guidance for revenue growth, non-GAAP operating margin expansion and non-GAAP EPS.

Q2 2021 revenue growth of 34.4% year-over-year; organic revenue growth of 27.2%.

Q2 2021 GAAP EPS of $0.38.

Q2 2021 non-GAAP EPS of $0.44, compared to $0.21 in Q2 2020.

Strong financial performance in the Bruker Scientific Instruments and BEST businesses drives a further increase in fiscal year 2021 guidance.

Total Revenue
$571M
Previous year: $425M
+34.4%
EPS
$0.44
Previous year: $0.21
+109.5%
Organic Revenue Growth
27.2%
Previous year: -12.7%
-314.2%
GAAP Operating Margin
15%
Previous year: 8.9%
+68.5%
Non-GAAP Operating Margin
17.3%
Previous year: 11.5%
+50.4%
Gross Profit
$281M
Previous year: $186M
+50.7%
Cash and Equivalents
$608M
Previous year: $747M
-18.6%
Free Cash Flow
-$700K
Previous year: -$26.7M
-97.4%
Total Assets
$3.09B
Previous year: $2.94B
+4.9%

Bruker

Bruker

Forward Guidance

Bruker is raising its fiscal year 2021 guidance for revenue growth, non-GAAP operating margin expansion and non-GAAP EPS.

Positive Outlook

  • Reported revenue growth of 17% to 19%.
  • Organic revenue growth of 14% to 16%.
  • Foreign currency revenue tailwind of 3%.
  • Non-GAAP operating margin expansion of 270 basis points to 310 basis points over FY 2020 non-GAAP operating margin of 16.0%, including a foreign currency headwind of 30 basis points in FY 2021.
  • Non-GAAP EPS between $1.88 and $1.93, representing a year-over-year increase of 39% to 43%.